Back to Agenda
How Can Three Parties- Payers, Industry and HTA - Make Agreements and Share the Economic Risk?
Session Chair(s)
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
This session will focus on how national integration between different parties can build a sustainable process to give true access to novel medicines based on the patients´ needs. In addition, the session will cover parts of the life cycle of a drug from registration, HTA, budgeting to implementation and actual access; it will also show what we can learn from some European examples like Sweden and the UK.
Speaker(s)
Richard Torbett, PhD, MA
Executive Director, Commercial , Association of the British Pharmaceutical Industry, United Kingdom
The Industry Perspective on Agreements, Shared Economic Risk and Access
Magnus Thyberg, MSc
Head of Department, Stockholm County Council, Sweden
The Payer Perspective on Agreements, Shared Economic Risk, and Access
Have an account?